Akane Yamamichi

705 total citations
25 papers, 400 citations indexed

About

Akane Yamamichi is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Akane Yamamichi has authored 25 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Genetics and 10 papers in Immunology. Recurrent topics in Akane Yamamichi's work include Glioma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (8 papers) and Immunotherapy and Immune Responses (5 papers). Akane Yamamichi is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (8 papers) and Immunotherapy and Immune Responses (5 papers). Akane Yamamichi collaborates with scholars based in Japan, United States and Sweden. Akane Yamamichi's co-authors include Hideho Okada, Atsushi Natsume, Akira Kato, Takahide Nejo, Kazuya Motomura, Fumiharu Ohka, Shunichiro Kuramitsu, Toshihiko Wakabayashi, Masasuke Ohno and Satoshi Shiina and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Akane Yamamichi

23 papers receiving 398 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Akane Yamamichi 221 147 108 100 90 25 400
Víctor A. Arrieta 179 0.8× 118 0.8× 167 1.5× 164 1.6× 151 1.7× 27 510
Axel Hyrenius‐Wittsten 277 1.3× 249 1.7× 117 1.1× 31 0.3× 124 1.4× 11 621
Maxim A. Moroz 275 1.2× 190 1.3× 84 0.8× 52 0.5× 146 1.6× 19 558
Anat Globerson Levin 226 1.0× 183 1.2× 135 1.3× 29 0.3× 104 1.2× 20 370
Cristina Corbetta 150 0.7× 118 0.8× 128 1.2× 144 1.4× 53 0.6× 9 351
Changlin Yang 263 1.2× 229 1.6× 295 2.7× 247 2.5× 95 1.1× 46 660
Anna Kruschinski 376 1.7× 307 2.1× 329 3.0× 65 0.7× 77 0.9× 26 711
Johanna Theruvath 390 1.8× 223 1.5× 318 2.9× 104 1.0× 179 2.0× 22 714
Anna C. Filley 315 1.4× 133 0.9× 225 2.1× 207 2.1× 59 0.7× 10 547
Sneha Berry 286 1.3× 242 1.6× 177 1.6× 53 0.5× 116 1.3× 17 617

Countries citing papers authored by Akane Yamamichi

Since Specialization
Citations

This map shows the geographic impact of Akane Yamamichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akane Yamamichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akane Yamamichi more than expected).

Fields of papers citing papers by Akane Yamamichi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akane Yamamichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akane Yamamichi. The network helps show where Akane Yamamichi may publish in the future.

Co-authorship network of co-authors of Akane Yamamichi

This figure shows the co-authorship network connecting the top 25 collaborators of Akane Yamamichi. A scholar is included among the top collaborators of Akane Yamamichi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akane Yamamichi. Akane Yamamichi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yutong, C.-S. Park, Akane Yamamichi, et al.. (2024). Ultrasound frequency-controlled microbubble dynamics in brain vessels regulate the enrichment of inflammatory pathways in the blood-brain barrier. Nature Communications. 15(1). 8021–8021. 18 indexed citations
2.
Hatae, Ryusuke, Akane Yamamichi, Tiffany Chen, et al.. (2024). Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment. JCI Insight. 9(7). 27 indexed citations
3.
Gallus, Marco, et al.. (2023). Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. Cancers. 15(14). 3726–3726. 11 indexed citations
4.
Nejo, Takahide, Saritha Krishna, Akane Yamamichi, et al.. (2023). 956 Glioma-neuronal circuit remodeling induces regional immunosuppression. SHILAP Revista de lepidopterología. A1062–A1063. 1 indexed citations
5.
Simic, Milos, Payal Watchmaker, Akane Yamamichi, et al.. (2023). 277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma. SHILAP Revista de lepidopterología. A317–A317. 1 indexed citations
6.
Nejo, Takahide, Saritha Krishna, Akane Yamamichi, et al.. (2023). CNSC-06. REDIRECTING IMMUNOSUPPRESSIVE GLIOMA MICROENVIRONMENT THROUGH PHARMACOLOGICAL INTERVENTION TARGETING NEURONAL ACTIVITY. Neuro-Oncology. 25(Supplement_5). v23–v23.
7.
Chalise, Lushun, Akira Kato, Masasuke Ohno, et al.. (2022). Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma. Molecular Therapy — Oncolytics. 26. 265–274. 46 indexed citations
8.
Chuntova, Pavlina, Yafei Hou, Akane Yamamichi, et al.. (2021). Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. Neuro-Oncology. 24(2). 259–272. 11 indexed citations
9.
Nishikawa, Tomohide, Reiko Watanabe, Yotaro Kitano, et al.. (2021). Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas. Brain Tumor Pathology. 39(1). 14–24. 9 indexed citations
10.
Nejo, Takahide, Akane Yamamichi, Neil D. Almeida, Yitzhar Goretsky, & Hideho Okada. (2020). Tumor antigens in glioma. Seminars in Immunology. 47. 101385–101385. 40 indexed citations
11.
Ranjit, Melissa, Masaki Hirano, Kosuke Aoki, et al.. (2019). Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma. Cell Reports. 26(9). 2274–2281.e5. 9 indexed citations
12.
Yamamichi, Akane, Fumiharu Ohka, Kosuke Aoki, et al.. (2018). Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion. Brain Tumor Pathology. 35(2). 106–113. 12 indexed citations
13.
Hirano, Masaki, Fumiharu Ohka, Sachi Maeda, et al.. (2018). A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR. Brain Tumor Pathology. 35(2). 97–105. 13 indexed citations
14.
Ohka, Fumiharu, Akane Yamamichi, Kazuya Motomura, et al.. (2017). A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma. Brain Tumor Pathology. 34(2). 91–97. 13 indexed citations
15.
Shimizu, Mikiko, Akira Kato, Kazuya Motomura, et al.. (2017). Remote ischemic preconditioning protects human neural stem cells from oxidative stress. APOPTOSIS. 22(11). 1353–1361. 10 indexed citations
16.
Shiina, Satoshi, Masasuke Ohno, Fumiharu Ohka, et al.. (2016). CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains. Cancer Immunology Research. 4(3). 259–268. 80 indexed citations
17.
Kuramitsu, Shunichiro, Akane Yamamichi, Fumiharu Ohka, et al.. (2016). Adoptive Immunotherapy for the Treatment of Glioblastoma: Progress and Possibilities. Immunotherapy. 8(12). 1393–1404. 8 indexed citations
18.
Kuramitsu, Shunichiro, Masasuke Ohno, Fumiharu Ohka, et al.. (2015). Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses. Cancer Gene Therapy. 22(10). 487–495. 53 indexed citations
19.
Suzuki, Hiromichi, Kosuke Aoki, Fumiharu Ohka, et al.. (2015). Rapid sensitive analysis ofIDH1mutation in lower-grade gliomas by automated genetic typing involving a quenching probe. Cancer Investigation. 34(1). 12–15. 4 indexed citations
20.
Toma, Naoki, et al.. (2009). Ascending pharyngeal-internal jugular arteriovenous fistula: case report. Journal of Neuroendovascular Therapy. 3(2). 100–105.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Víctor A. Arrieta Breakdown of academic impact, for papers by Axel Hyrenius‐Wittsten Breakdown of academic impact, for papers by Maxim A. Moroz Breakdown of academic impact, for papers by Anat Globerson Levin Breakdown of academic impact, for papers by Cristina Corbetta Breakdown of academic impact, for papers by Changlin Yang Breakdown of academic impact, for papers by Anna Kruschinski Breakdown of academic impact, for papers by Johanna Theruvath Breakdown of academic impact, for papers by Anna C. Filley Breakdown of academic impact, for papers by Sneha Berry
Rankless by CCL
2026